{"id":94,"date":"2023-09-14T10:09:11","date_gmt":"2023-09-14T17:09:11","guid":{"rendered":"https:\/\/depts.washington.edu\/drainglobalresearch\/?page_id=94"},"modified":"2024-10-22T11:59:48","modified_gmt":"2024-10-22T18:59:48","slug":"research","status":"publish","type":"page","link":"https:\/\/depts.washington.edu\/drainglobalresearch\/research\/","title":{"rendered":"Research"},"content":{"rendered":"<h2>Research Overview<\/h2>\n<p>Our Global Research Group is dedicated to conducting patient-oriented clinical and translational biomedical research aimed at reducing morbidity and mortality for tuberculosis (TB), HIV, malaria, STIs, and other infectious diseases of significance in resource-limited settings.<\/p>\n<p>Our clinical research program has centered on the evaluation of novel rapid diagnostic tests, clinical trials to evaluate point-of-care testing interventions, and applying implementation science frameworks for methods to accelerate treatment and improve patient-centered outcomes. We have been conducting translational, clinical and implementation science research, including randomized controlled trials, in sub-Saharan Africa since 2003, and in south-east Asia since 2015. Our research group consists of Research Scientists, doctoral and masters graduate students, medical students, and undergraduates.  We have developed and maintained strong research collaborations in South Africa, Kenya, Thailand, Uganda, Brazil, Bangladesh, and Vietnam.<\/p>\n<p>Our work spans clinical epidemiology, where we study patient outcomes and healthcare utilization related to communicable diseases; implementation science, focusing on bridging the gap between laboratory research and clinical setting; and diagnostics, aimed at developing and evaluating innovative diagnostic tools for early detection of infectious diseases. Our research program has been funded through several institute of the National Institutes of Health, including NIAID, NICHD, NIBIB, NIMH, and Fogarty International Center, the US Centers for Disease Control (CDC), the Bill and Melinda Gates Foundation, and several industry partners.  In addition, Dr. Drain serves as the Director of Clinical Research for the International Clinical Research Center (ICRC), the Director of the Clinical and Translational Science Core for the Seattle Tuberculosis Research Advancement Center (Sea-TRAC), and has been a standing member of the Guideline Committee on HIV Treatment and Monitoring at the World Health Organization.<\/p>\n<p>Our commitment to diversity, equity, and inclusion (DEI) ensures that diverse perspectives are represented and valued in our work. We believe that collaboration across disciplines and geographies enhances the impact of our research. Additionally, we actively work towards the decolonization of global health by challenging traditional power dynamics and prioritizing local leadership and expertise in our research efforts.<\/p>\n<h2>Research Focus Areas<\/h2>\n<div class=\"content_block\" id=\"custom_post_widget-278\">\n<div  class=\"grid row equal   \" >\n<div  class=\"col-12 col-xs-12 col-sm-12 col-md-6 col-lg-6 col-xl-6 col-xxl-3 pt-3 pr-3 pb-3 pl-3\">\n<h4>HIV<\/h4>\n<div class=\"udub-slant-divider udub-slant-divider-uwdgh-shortcode-adds \"><span><\/span><\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-264\" data-toggle=\"modal\" data-target=\"#uw-modal-264\"><span class=\"btn-label\">STREAM HIV Study<\/span><\/button><\/p>\n<div id=\"uw-modal-264\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-264Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-264Title\">STREAM HIV Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-264\" title=\"STREAM HIV Study\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"68\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_STREAM-HIV-300x68.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_STREAM-HIV-300x68.png 300w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_STREAM-HIV-375x85.png 375w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_STREAM-HIV.png 460w\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<ul>\n<li><strong>Title<\/strong>: Simplifying HIV Treatment and Monitoring (STREAM2): Point-of-Care Urine Tenofovir Adherence and Viral Load Testing to Improve HIV Outcomes in South Africa<\/li>\n<li><strong>Major Goals<\/strong>: In this study, we will evaluate a combined implementation of clinic-based point-of-care HIV viral load testing and task shifting among healthcare workers as a novel and effective strategy for managing chronic HIV care in low and middle-income countries.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIAID; R01 AI 147752<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-249\" data-toggle=\"modal\" data-target=\"#uw-modal-249\"><span class=\"btn-label\">DREAM Resistance Study<\/span><\/button><\/p>\n<div id=\"uw-modal-249\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-249Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-249Title\">DREAM Resistance Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-249\" title=\"DREAM Resistance Study\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"118\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_DREAM-300x118.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_DREAM-300x118.png 300w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_DREAM-1024x402.png 1024w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_DREAM-768x301.png 768w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_DREAM-375x147.png 375w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_DREAM-1200x471.png 1200w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_DREAM.png 1435w\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<p><strong>Title<\/strong>: Drug Resistance Genotypic and Phenotypic Correlates of Efavirenz and Dolutegravir based Treatment Outcomes across Non-B HIV-1 Subtypes<br \/>\n<strong>Major Goals<\/strong>: This proposal seeks to expand our understanding of HIV drug resistance and its correlates and consequences in low and middle income counties where HIV-1 non-B subtypes circulate.<br \/>\n<strong>Source of Support<\/strong>: NIH\/NIAID, R01 AI 147309<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-295\" data-toggle=\"modal\" data-target=\"#uw-modal-295\"><span class=\"btn-label\">RESTRICT Study<\/span><\/button><\/p>\n<div id=\"uw-modal-295\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-295Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-295Title\">RESTRICT Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-295\" title=\"RESTRICT Study\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: A novel REverSe Transcriptase Chain Termination (RESTRICT) assay for near-patient, objective monitoring of long-term PrEP adherence<\/li>\n<li><strong>Major Goals<\/strong>: In this proposal, we will optimize the REverSe TRanscrIptase Chain Termination (RESTRICT) assay to measure TFVDP concentrations in PrEP clients, validate the assay to meet CLIA requirements, and conduct a feasibility and acceptability study among PrEP clients and providers.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIAID;\u00a0 R01 AI 157756<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-292\" data-toggle=\"modal\" data-target=\"#uw-modal-292\"><span class=\"btn-label\">V-OLA HIV Study<\/span><\/button><\/p>\n<div id=\"uw-modal-292\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-292Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-292Title\">V-OLA HIV Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-292\" title=\"V-OLA HIV Study\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: V-OLA: point of care HIV viral load monitoring and drug resistance testing<\/li>\n<li><strong>Major Goals<\/strong>: The goal of this study is to develop the first test for detection of viral load and HIV drug resistance that is appropriate for use in low-resource settings.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIAID; R01 AI 145486<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-323\" data-toggle=\"modal\" data-target=\"#uw-modal-323\"><span class=\"btn-label\">PUMA Study<\/span><\/button><\/p>\n<div id=\"uw-modal-323\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-323Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-323Title\">PUMA Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-323\" title=\"PUMA Study\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Point-of-care Urine Monitoring of Adherence (PUMA):\u00a0 Testing a Real-Time Urine Assay of Tenofovir in PrEP<\/li>\n<li><strong>Major Goals<\/strong>: The goal of this project is to examine a novel urine-based immunoassay to tenofovir as a real-time metric of adherence to PrEP. We will use data from a directly-observed therapy study of tenofovir to package the antibody-based assay into a point-of-care assay; look at the correlation between urine levels via this immunoassay with plasma levels in Partners PrEP; and perform a pilot study among women in Kenya on PrEP of the impact of real-time monitoring and feedback using this assay on adherence.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIAID;\u00a0 R01 AI 143340<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-332\" data-toggle=\"modal\" data-target=\"#uw-modal-332\"><span class=\"btn-label\">Standing Tall<\/span><\/button><\/p>\n<div id=\"uw-modal-332\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-332Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-332Title\">Standing Tall<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-332\" title=\"Standing Tall\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Standing Tall &#8211; A Pilot Randomized Controlled Trial of a Community-Based Intervention to Improve Health Outcomes for Newly Diagnosed HIV-Positive Young Adults in South Africa<\/li>\n<li><strong>Major Goals<\/strong>: The work proposed in this administrative supplement will provide critical insight into the acceptability and feasibility of rapid ART scale-up among HIV-positive adolescents and young adults, as well as the potential role for POC testing.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIMH;\u00a0 R34MH114897<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-339\" data-toggle=\"modal\" data-target=\"#uw-modal-339\"><span class=\"btn-label\">Head Start Study<\/span><\/button><\/p>\n<div id=\"uw-modal-339\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-339Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-339Title\">Head Start Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-339\" title=\"Head Start Study\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Achieving HIV viral suppression in refugee settlements in Uganda with Head StART: a cluster randomized trial evaluating the effectiveness of community ART delivery for people newly diagnosed with HIV<\/li>\n<li><strong>Major Goals<\/strong>: The overall objective of this study is to conduct a cluster randomized controlled trial to discern the effectiveness of \u201cHead StART,\u201d community ART delivery for those newly<br \/>\ndiagnosed with HIV, compared to standard care (facility-based ART delivery) to achieve HIV viral.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIMH; R01MH130216-01A1<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div  class=\"col-12 col-xs-12 col-sm-12 col-md-6 col-lg-6 col-xl-6 col-xxl-3 pt-3 pr-3 pb-3 pl-3\">\n<h4>TB<\/h4>\n<div class=\"udub-slant-divider udub-slant-divider-uwdgh-shortcode-adds \"><span><\/span><\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-288\" data-toggle=\"modal\" data-target=\"#uw-modal-288\"><span class=\"btn-label\">Prove TB Study<\/span><\/button><\/p>\n<div id=\"uw-modal-288\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-288Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-288Title\">Prove TB Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-288\" title=\"Prove TB Study\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"98\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB-300x98.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB-300x98.png 300w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB-375x123.png 375w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB.png 599w\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<ul>\n<li><strong>Title<\/strong>: Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal, South Africa: The PROVE TB Study<\/li>\n<li><strong>Major Goals<\/strong>: The goal of this study is to conduct prospective clinical evaluations of emerging TB diagnostics, with an emphasis on novel urine LAM assays, among adults and children in a high TB-burden setting of KwaZulu-Natal, South Africa. This grant will be used to maintain a biorepository of well-characterized clinical specimens that can be used for either for retrospective validation of TB diagnostic or to share with partners developing novel TB diagnostics, including new LAM antibodies.<\/li>\n<li><strong>Source of Support<\/strong>: Bill &amp; Melinda Gates Foundation;\u00a0 OPP1213504<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-298\" data-toggle=\"modal\" data-target=\"#uw-modal-298\"><span class=\"btn-label\">Prove TB-Vietnam Study<\/span><\/button><\/p>\n<div id=\"uw-modal-298\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-298Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-298Title\">Prove TB-Vietnam Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-298\" title=\"Prove TB-Vietnam Study\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"98\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB-300x98.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB-300x98.png 300w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB-375x123.png 375w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_ProveTB.png 599w\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<ul>\n<li><strong>Title<\/strong>: Development of a reference assay and standards to harmonize measurement of TB LAM in urine<\/li>\n<li><strong>Major Goals<\/strong>: Prospective Evaluation of Novel Diagnostics for Tuberculosis in Ha Noi, Viet Nam&#8221; (PROVE-TB-VN).<\/li>\n<li><strong>Source of Support<\/strong>: Bill &amp; Melinda Gates Foundation; OPP1208704<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-305\" data-toggle=\"modal\" data-target=\"#uw-modal-305\"><span class=\"btn-label\">Oral Swab for TB Diagnosis<\/span><\/button><\/p>\n<div id=\"uw-modal-305\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-305Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-305Title\">Oral Swab for TB Diagnosis<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-305\" title=\"Oral Swab for TB Diagnosis\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Development of methods for use of oral swab in TB diagnosis<\/li>\n<li><strong>Major Goals<\/strong>: This project will further the development of methods for detecting Mycobacterium tuberculosis (MTB) DNA in non-invasive oral swab samples in relevant clinical settings. It will also evaluate user attitudes toward oral sample analysis (OSA), and evaluate OSA as means to find the \u201cmissing millions\u201d of undiagnosed TB cases.<\/li>\n<li><strong>Source of Support<\/strong>: Bill &amp; Melinda Gates Foundation; INV-004527<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-312\" data-toggle=\"modal\" data-target=\"#uw-modal-312\"><span class=\"btn-label\">Urine cell-free DNA for TB<\/span><\/button><\/p>\n<div id=\"uw-modal-312\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-312Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-312Title\">Urine cell-free DNA for TB<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-312\" title=\"Urine cell-free DNA for TB\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Transrenal DNA for point-of-care diagnosis of TB<\/li>\n<li><strong>Major Goals<\/strong>: We aim to develop a test for TB using an easily-collected urine sample.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIAID; R21 AI163613-01<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-326\" data-toggle=\"modal\" data-target=\"#uw-modal-326\"><span class=\"btn-label\">Pediatric TB-FLOW Study<\/span><\/button><\/p>\n<div id=\"uw-modal-326\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-326Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-326Title\">Pediatric TB-FLOW Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-326\" title=\"Pediatric TB-FLOW Study\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology<\/li>\n<li><strong>Major Goals<\/strong>: To optimize and adapt Salus\u2019 urine-based FLOW technology for the diagnosis of tuberculosis in pediatric patients<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NICHD; R43\/R44 HD101201A<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-329\" data-toggle=\"modal\" data-target=\"#uw-modal-329\"><span class=\"btn-label\">TBESC 3<\/span><\/button><\/p>\n<div id=\"uw-modal-329\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-329Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-329Title\">TBESC 3<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-329\" title=\"TBESC 3\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Tuberculosis Epidemiologic Studies Consortium III Support Services<\/li>\n<li><strong>Major Goals<\/strong>: The purpose of this grant is to establish a multicenter epidemiologic research study using the principles of implementation science to identify the characteristics of LTBI targeted testing and treatment programs that are associated with the greatest effectiveness.<\/li>\n<li><strong>Source of Support<\/strong>: US Centers for Disease Control; 75D30121C12880<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-335\" data-toggle=\"modal\" data-target=\"#uw-modal-335\"><span class=\"btn-label\">Abbott hsLAM<\/span><\/button><\/p>\n<div id=\"uw-modal-335\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-335Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-335Title\">Abbott hsLAM<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-335\" title=\"Abbott hsLAM\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"77\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_Abbott-300x77.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_Abbott-300x77.jpg 300w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_Abbott-1024x262.jpg 1024w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_Abbott-768x196.jpg 768w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_Abbott-375x96.jpg 375w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_Abbott-1200x307.jpg 1200w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_Abbott.jpg 1280w\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<ul>\n<li><strong>Title<\/strong>: Clinical Validation of a High-Sensitivity Urine LAM Assay<\/li>\n<li><strong>Major Goals<\/strong>: The work proposed aims to validated a new urine hsLAM assay and defined the optimal diagnostic algorithms among the target populations of adults and children in several high-priority TB-endemic countries.<\/li>\n<li><strong>Source of Support<\/strong>: Abbott Laboratories; 15662006<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-316\" data-toggle=\"modal\" data-target=\"#uw-modal-316\"><span class=\"btn-label\">Sea-TRAC<\/span><\/button><\/p>\n<div id=\"uw-modal-316\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-316Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-316Title\">Sea-TRAC<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-316\" title=\"Sea-TRAC\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"151\" height=\"44\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_SEATRAC.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<ul>\n<li><strong>Title<\/strong>: Seattle Tuberculosis Research Advancement Center &#8211; Clinical and Translational Science Core (\u201cCTSC\u201d)<\/li>\n<li><strong>Major Goals<\/strong>: The CTSC will strengthen clinical and translational TB research through training and consultation in clinical science methodology and support of local collaborations; strengthen TB clinical research by developing and expanding partnerships with national and international collaborators conducting clinical and translational research in TB; and foster and catalyze collaborations with investigators with established cohorts, robust clinical databases, and biospecimens for advancing basic, translation, and clinical TB research.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NIAID;\u00a0 1P30AI168034-01<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-308\" data-toggle=\"modal\" data-target=\"#uw-modal-308\"><span class=\"btn-label\">TRTC<\/span><\/button><\/p>\n<div id=\"uw-modal-308\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-308Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-308Title\">TRTC<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-308\" title=\"TRTC\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"63\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC-300x63.jpg\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC-300x63.jpg 300w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC-1024x216.jpg 1024w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC-768x162.jpg 768w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC-1536x323.jpg 1536w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC-375x79.jpg 375w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC-1200x253.jpg 1200w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_TRTC.jpg 1563w\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<ul>\n<li><strong>Title<\/strong>: UW TB Research &amp; Training Center (TRTC)<\/li>\n<li><strong>Major Goals<\/strong>: The goal of this grant is to support the UW TB Research &amp; Training Center which fosters innovation and collaboration among investigators, trainees, and local institutions in Seattle.<\/li>\n<li><strong>Source of Support<\/strong>: Bill &amp; Melinda Gates Foundation;\u00a0 OPP1187752<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div  class=\"col-12 col-xs-12 col-sm-12 col-md-6 col-lg-6 col-xl-6 col-xxl-3 pt-3 pr-3 pb-3 pl-3\">\n<h4>COVID<\/h4>\n<div class=\"udub-slant-divider udub-slant-divider-uwdgh-shortcode-adds \"><span><\/span><\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-301\" data-toggle=\"modal\" data-target=\"#uw-modal-301\"><span class=\"btn-label\">InBios Covid Study<\/span><\/button><\/p>\n<div id=\"uw-modal-301\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-301Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-301Title\">InBios Covid Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-301\" title=\"InBios Covid Study\">\n<p class='text-center'><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"131\" src=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios-300x131.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"\" srcset=\"https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios-300x131.png 300w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios-1024x448.png 1024w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios-768x336.png 768w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios-1536x672.png 1536w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios-375x164.png 375w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios-1200x525.png 1200w, https:\/\/depts.washington.edu\/drainglobalresearch\/wordpress\/wp-content\/uploads\/2023\/10\/project_InBios.png 1600w\" sizes=\"auto, 100vw\" \/><\/p>\n<div>\n<ul>\n<li><strong>Title<\/strong>: Development of an FDA-cleared Rapid Diagnostic Tests to Detect Biomarkers of SARS-COV-2 Infection<\/li>\n<li><strong>Major Goals<\/strong>: The primary objective of the study is to evaluate the positive percent agreement (PPA) and negative percent agreement (NPA) of the SCoV-2 Ag Detect\u2122 Rapid Self-Test used in a non-laboratory setting by lay users compared to a reference test, a SARS-CoV-2 RT-PCR test that has received emergency use authorization (EUA) from the FDA. Paired anterior nasal swab specimens will be prospectively collected from enrolled subjects with symptoms of respiratory infection consistent with SARS-CoV-2 infection within 5 days of the subject\u2019s first onset of symptoms. The study endpoint will be achieved when at least 30 unique PCR positive subjects and at least 150 subjects total are enrolled and tested from multiple sites.<\/li>\n<li><strong>Source of Support<\/strong>: US Department of Defense; W81XWH-16-D-0009<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-320\" data-toggle=\"modal\" data-target=\"#uw-modal-320\"><span class=\"btn-label\">ROSSEY Study<\/span><\/button><\/p>\n<div id=\"uw-modal-320\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-320Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-320Title\">ROSSEY Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-320\" title=\"ROSSEY Study\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Using COVID-19 Testing and Risk Communication Strategies to Accelerate Children\u2019s Return to School<\/li>\n<li><strong>Major Goals<\/strong>: This project proposes to develop, test, and evaluate risk communication strategies on COVID-19 preventive behaviors, COVID-19 testing, and vaccination using a cluster randomized controlled trial. The study partners with a large school district and will recruit 900 Hispanic families.<\/li>\n<li><strong>Source of Support<\/strong>: NIH\/NICHD; 1OT2HD107544-02<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div  class=\"col-12 col-xs-12 col-sm-12 col-md-6 col-lg-6 col-xl-6 col-xxl-3 pt-3 pr-3 pb-3 pl-3\">\n<h4>Rapid Diagnostic Testing<\/h4>\n<div class=\"udub-slant-divider udub-slant-divider-uwdgh-shortcode-adds \"><span><\/span><\/div>\n<p class=\"uw-modal-button-stretched\">\t<button type=\"button\" class=\"btn btn-lg btn-modal secondary uw-modal-342\" data-toggle=\"modal\" data-target=\"#uw-modal-342\"><span class=\"btn-label\">DASH Study<\/span><\/button><\/p>\n<div id=\"uw-modal-342\" class=\"modal fade\" tabindex=\"-1\" role=\"dialog\" aria-labelledby=\"uw-modal-342Title\" aria-hidden=\"true\">\n<div class=\"modal-dialog w-60  modal-dialog-centered\" role=\"document\">\n<div class=\"modal-content\">\n<div class=\"modal-header\">\n<h2 class=\"h5 modal-title\" id=\"uw-modal-342Title\">DASH Study<\/h2>\n<p>\t\t\t\t\t<button type=\"button\" class=\"close\" data-dismiss=\"modal\" aria-label=\"Close\"><span aria-hidden=\"true\">&times;<\/span><\/button>\n\t\t\t\t<\/div>\n<div class=\"modal-body\">\n<div class=\"content_block content-block-project-modal\" id=\"custom_post_widget-342\" title=\"DASH Study\">\n<div>\n<ul>\n<li><strong>Title<\/strong>: Rapid Diagnostic-Facilitated Access to Self-Care &amp; Health Services<\/li>\n<li><strong>Major Goals<\/strong>: To develop and evaluate an integrated self-care rapid diagnostic testing package(s) that will facilitate home- or community-based screening, testing, and treatment initiation for both infectious and chronic non-communicable diseases (NCDs) in LMICs.<\/li>\n<li><strong>Source of Support<\/strong>: Bill and Melinda Gates Foundation; INV-050665<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Research Overview Our Global Research Group is dedicated to conducting patient-oriented clinical and translational biomedical research aimed at reducing morbidity and mortality for tuberculosis (TB), HIV, malaria, STIs, and other infectious diseases of significance in resource-limited settings. Our clinical research program has centered on the evaluation of novel rapid diagnostic tests, clinical trials to evaluate point-of-care testing interventions, and applying implementation science frameworks for methods to accelerate treatment and improve patient-centered outcomes. We have been conducting translational, clinical and implementation&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_members_access_role":[],"_members_access_error":""},"class_list":["post-94","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/pages\/94","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/comments?post=94"}],"version-history":[{"count":9,"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/pages\/94\/revisions"}],"predecessor-version":[{"id":656,"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/pages\/94\/revisions\/656"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/drainglobalresearch\/wp-json\/wp\/v2\/media?parent=94"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}